Literature DB >> 1829516

Replication of adenovirus type 4 DNA by a purified fraction from infected cells.

S M Temperley1, R T Hay.   

Abstract

An extract from Adenovirus type 4 infected HeLa cells was fractionated by ion-exchange and DNA affinity chromatography. One fraction, which bound tightly to single stranded DNA, contained predominantly a protein of apparent molecular weight 65,000 and three less abundant proteins. Immunological cross-reactivity with adenovirus type 2 proteins confirmed the presence of preterminal protein and indicated that the abundant species was the virus coded DNA binding protein. This fraction contained an aphidicolin resistant DNA polymerase activity and in the presence of a linearised plasmid containing the adenovirus type 4 origin of DNA replication efficient transfer of dCMP onto preterminal protein, indicative of initiation, was observed. Furthermore, addition of all four deoxyribonucleotide triphosphates and an ATP regenerating system resulted in the elongation of initiated molecules to generate plasmid molecules covalently attached to preterminal protein. Adenovirus type 4 DNA binding protein was extensively purified from crude adenovirus-4 infected HeLa extract by immunoaffinity chromatography using a monoclonal antibody raised against adenovirus type 2 DNA binding protein. A low level of initiation of DNA replication was detected in the fraction depleted of DNA binding protein but activity was restored by addition of purified DNA binding protein. DNA binding protein therefore plays an important role in the initiation of Ad4 DNA replication.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1829516      PMCID: PMC328317          DOI: 10.1093/nar/19.12.3243

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  43 in total

1.  Identification of a protein linked to the ends of adenovirus DNA.

Authors:  D M Rekosh; W C Russell; A J Bellet; A J Robinson
Journal:  Cell       Date:  1977-06       Impact factor: 41.582

2.  Enhancement of adenovirus plaque formation on HeLa cells by magnesium chloride.

Authors:  J F Williams
Journal:  J Gen Virol       Date:  1970-12       Impact factor: 3.891

3.  Protein-primed replication of plasmids containing the terminus of the adenovirus genome. II. Purification and characterization of a host protein required for the replication of DNA templates devoid of the terminal protein.

Authors:  R A Guggenheimer; K Nagata; M Kenny; J Hurwitz
Journal:  J Biol Chem       Date:  1984-06-25       Impact factor: 5.157

4.  Template requirements for the initiation of adenovirus DNA replication.

Authors:  M D Challberg; D R Rawlins
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

5.  Replication of adenovirus mini-chromosomes.

Authors:  R T Hay; N D Stow; I M McDougall
Journal:  J Mol Biol       Date:  1984-06-05       Impact factor: 5.469

6.  Adenovirus DNA replication in vitro: purification of the terminal protein in a functional form.

Authors:  T Enomoto; J H Lichy; J E Ikeda; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

7.  The infectivity of adenovirus genomes lacking DNA sequences from their left-hand termini.

Authors:  N D Stow
Journal:  Nucleic Acids Res       Date:  1982-09-11       Impact factor: 16.971

8.  Structure and function of the adenovirus origin of replication.

Authors:  D R Rawlins; P J Rosenfeld; R J Wides; M D Challberg; T J Kelly
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

9.  Specific binding of a cellular DNA replication protein to the origin of replication of adenovirus DNA.

Authors:  K Nagata; R A Guggenheimer; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

10.  Monoclonal antibodies which recognize native and denatured forms of the adenovirus DNA-binding protein.

Authors:  N C Reich; P Sarnow; E Duprey; A J Levine
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

View more
  9 in total

1.  Identification of conserved residues contributing to the activities of adenovirus DNA polymerase.

Authors:  H Liu; J H Naismith; R T Hay
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Nuclear factor I is specifically targeted to discrete subnuclear sites in adenovirus type 2-infected cells.

Authors:  J Bosher; A Dawson; R T Hay
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  Adenovirus DNA polymerase: domain organisation and interaction with preterminal protein.

Authors:  E J Parker; C H Botting; A Webster; R T Hay
Journal:  Nucleic Acids Res       Date:  1998-03-01       Impact factor: 16.971

4.  Insufficient levels of NFIII and its low affinity for the origin of adenovirus type 12 (Ad12) DNA replication contribute to the abortive infection of BHK21 hamster cells by Ad12.

Authors:  G Schiedner; W Doerfler
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Activation of adenovirus-coded protease and processing of preterminal protein.

Authors:  A Webster; I R Leith; R T Hay
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

6.  Adenovirus DNA binding protein: helix destabilising properties.

Authors:  A Monaghan; A Webster; R T Hay
Journal:  Nucleic Acids Res       Date:  1994-03-11       Impact factor: 16.971

7.  Identification of two distinct regions within the adenovirus minimal origin of replication that are required for adenovirus type 4 DNA replication in vitro.

Authors:  S M Temperley; C R Burrow; T J Kelly; R T Hay
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

8.  PML Alternative Splice Products Differentially Regulate HAdV Productive Infection.

Authors:  Julia Mai; Miona Stubbe; Samuel Hofmann; Sawinee Masser; Thomas Dobner; Christopher Boutell; Peter Groitl; Sabrina Schreiner
Journal:  Microbiol Spectr       Date:  2022-06-14

9.  Recognition of the adenovirus type 2 origin of DNA replication by the virally encoded DNA polymerase and preterminal proteins.

Authors:  S M Temperley; R T Hay
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.